ACM Research, Inc. (ACMR) is a publicly traded American semiconductor company that engages in the manufacture and sale of single-wafer wet cleaning equipment used to improve product yield. Although based in the U.S., the majority of the company's business is done in China through its subsidiary, ACM Research (Shanghai).
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| ACMR | ACM Research, Inc. | 2025-12-02 08:27:11 | 33.81 | 0.5 | 1.5 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACMR | 0001680062 | ACM Research, Inc. | US00108J1097 | 549300MCTENUWL2GJL61 | — | Nasdaq | 3559 | Special Industry Machinery, NEC | 1231 | CA | 42307 OSGOOD ROAD, SUITE I | FREMONT | CA | 94539 | UNITED STATES | US | 510-445-3700 | 42307 OSGOOD ROAD, SUITE I, FREMONT, CA, 94539 | 42307 OSGOOD ROAD, SUITE I, FREMONT, CA, 94539 | — | Semiconductors | 1998 | David Wang | 1,590 | https://acmr.com | 1,105,500,000 | — | 14,176,690 | ACM Research, Inc. (ACMR) is a publicly traded American semiconductor company that engages in the manufacture and sale of single-wafer wet cleaning equipment used to improve product yield. Although based in the U.S., the majority of the company's business is done in China through its subsidiary, ACM Research (Shanghai). | 2025-11-27 16:37:26 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 1,105,500,000 | 468,100,000 | 73.439 | — | — | — |
| 2023 | 637,400,000 | -101,600,000 | -13.7483 | — | — | — |
| 2022 | 739,000,000 | -1,241,600,000 | -62.6881 | — | — | — |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jian Wang | President, Chief Executive Officer | 2023 | 203,317 | 170,280 | — | — | 3,674 | 9,199,536 |
| Lisa Feng | Chief Financial Officer | 2023 | 196,532 | 93,654 | — | — | 4,264 | 4,273,155 |
| David H. Wang | President, Chief Executive Officer | 2023 | 256,212 | 205,755 | — | — | 4,264 | 23,533,975 |
| Mark Mckechnie | Chief Financial Officer, Secretary, Treasurer | 2023 | 273,675 | 37,500 | — | — | 0 | 3,425,025 |
| Fuping Chen | Vice President | 2023 | 157,845 | 170,280 | — | — | 0 | 7,158,266 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 2,023 |
| 2023 | 1,590 |
| 2022 | 1,209 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 782,118,000 | 557,723,000 | 388,832,000 |
| Cost Of Revenue | 390,564,000 | 281,508,000 | 205,217,000 |
| Gross Profit | 391,554,000 | 276,215,000 | 183,615,000 |
| Research And Development Expenses | 105,473,000 | 92,709,000 | 62,226,000 |
| General And Administrative Expenses | 69,636,000 | 40,648,000 | 22,465,000 |
| Operating Expenses | 240,556,000 | 180,376,000 | 124,580,000 |
| Operating Income | 150,998,000 | 95,839,000 | 59,035,000 |
| Net Income | 103,627,000 | 77,349,000 | 39,263,000 |
| Earnings Per Share Basic | 1.67 | 1.29 | 0.66 |
| Earnings Per Share Diluted | 1.53 | 1.16 | 0.59 |
| Weighted Average Shares Outstanding Basic | 62,212,569 | 60,164,670 | 59,235,975 |
| Weighted Average Shares Outstanding Diluted | 66,237,424 | 64,870,543 | 65,341,771 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 407,445,000 | 182,090,000 | 247,951,000 |
| Marketable Securities Current | 19,373,000 | 21,312,000 | 20,209,000 |
| Accounts Receivable | 387,045,000 | 283,186,000 | 182,936,000 |
| Inventories | 597,984,000 | 545,395,000 | 393,172,000 |
| Non Trade Receivables | — | — | 0 |
| Other Assets Current | 7,507,000 | 20,023,000 | 15,607,000 |
| Total Assets Current | 1,483,379,000 | 1,176,110,000 | 963,806,000 |
| Marketable Securities Non Current | 37,063,000 | 27,880,000 | 17,459,000 |
| Property Plant And Equipment | 269,272,000 | 201,848,000 | 82,875,000 |
| Other Assets Non Current | 20,452,000 | 6,050,000 | 50,265,000 |
| Total Assets Non Current | 307,219,000 | 223,191,000 | 144,321,000 |
| Total Assets | 1,855,721,000 | 1,490,908,000 | 1,235,500,000 |
| Accounts Payable | 16,133,000 | 11,407,000 | 101,735,000 |
| Deferred Revenue | 243,949,000 | 181,368,000 | 153,773,000 |
| Short Term Debt | 32,814,000 | 31,335,000 | 56,004,000 |
| Other Liabilities Current | 12,779,000 | 6,401,000 | 3,469,000 |
| Total Liabilities Current | 641,233,000 | 500,659,000 | 396,214,000 |
| Long Term Debt | 149,997,000 | 60,735,000 | 21,009,000 |
| Other Liabilities Non Current | 9,217,000 | 5,873,000 | 7,321,000 |
| Total Liabilities Non Current | 118,582,000 | 64,087,000 | 27,115,000 |
| Total Liabilities | 759,815,000 | 564,746,000 | 423,329,000 |
| Common Stock | 6,000 | 6,000 | 5,000 |
| Retained Earnings | 260,000,000 | 156,827,000 | 94,426,000 |
| Accumulated Other Comprehensive Income | -63,372,000 | -49,349,000 | -40,546,000 |
| Total Shareholders Equity | 904,625,000 | 767,390,000 | 674,856,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 9,967,000 | 8,092,000 | 5,366,000 |
| Share Based Compensation Expense | 49,576,000 | 27,338,000 | 7,730,000 |
| Other Non Cash Income Expense | -945,000 | 2,000 | 12,000 |
| Change In Accounts Receivable | 123,277,000 | 108,749,000 | 88,655,000 |
| Change In Inventories | 64,135,000 | 164,027,000 | 193,314,000 |
| Change In Non Trade Receivables | 3,812,000 | 4,213,000 | 7,331,000 |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 1,440,000 | 42,343,000 | 17,501,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 152,450,000 | -75,323,000 | -62,194,000 |
| Purchases Of Marketable Securities | 1,391,000 | 18,356,000 | 4,279,000 |
| Sales Of Marketable Securities | 8,434,000 | 21,735,000 | 4,577,000 |
| Acquisition Of Property Plant And Equipment | 82,463,000 | 61,876,000 | 91,094,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -11,959,000 | -6,745,000 | -265,670,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 96,896,000 | 42,360,000 | 0 |
| Repayment Of Long Term Debt | 9,582,000 | 55,068,000 | 9,224,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 92,481,000 | 18,530,000 | 45,871,000 |
| Change In Cash | 228,137,000 | -65,278,000 | -314,616,000 |
| Cash At End Of Period | 407,445,000 | 182,090,000 | 247,951,000 |
| Income Taxes Paid | 11,216,000 | 26,103,000 | 3,586,000 |
| Interest Paid | 4,151,000 | 2,681,000 | 1,655,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 1.67 | 1.29 | 0.66 |
| Price To Earnings Ratio | 9.0419 | 15.1473 | 11.6818 |
| Earnings Growth Rate | 29.4574 | 95.4545 | -66.3265 |
| Price Earnings To Growth Ratio | 0.3069 | 0.1587 | -0.1761 |
| Book Value Per Share | 17.6155 | 15.3938 | 13.7108 |
| Price To Book Ratio | 0.8572 | 1.2693 | 0.5623 |
| Ebitda | 127,743,000 | 114,225,000 | 49,870,000 |
| Enterprise Value | 714,775,791.9 | 1,085,597,651.8 | 285,771,367.25 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.2021 | 0.12 | 0.1141 |
| Capital Expenditures | 77,391,000 | 127,065,000 | 74,199,000 |
| Free Cash Flow | 75,059,000 | -202,388,000 | -136,393,000 |
| Return On Equity | 0.1146 | 0.1008 | 0.0582 |
| One Year Beta | 2.4604 | 2.4309 | 2.0851 |
| Three Year Beta | 2.2046 | 2.1642 | 1.6146 |
| Five Year Beta | 1.7319 | 1.6798 | 1.5258 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Feng Lisa | — | 2025-11-13 | 15,000 | A | 65,001 |
| Feng Lisa | — | 2025-11-13 | 15,000 | D | 50,001 |
| Feng Lisa | — | 2025-11-13 | 15,000 | D | 0 |
| Feng Lisa | — | 2025-11-12 | 15,000 | A | 65,001 |
| Feng Lisa | — | 2025-11-12 | 15,000 | D | 50,001 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Strategic Advocates LLC | 2025-09-30 | 1,370 | 35 | 39.1429 |
| JPMORGAN CHASE & CO | 2025-09-30 | 1,122,562 | 28,688 | 39.13 |
| CIBC Private Wealth Group LLC | 2025-09-30 | 1,291 | 33 | 39.1212 |
| Advisory Services Network, LLC | 2025-09-30 | 1,605 | 41 | 39.1463 |
| Pictet Asset Management Holding SA | 2025-09-30 | 1,991,443 | 50,893 | 39.13 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| JAMES ADVANTAGE FUNDS | 2025-09-30 | James Small Cap Fund | JASCX | 20,412 | 798,721.56 | 1.0982 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYCMX | 71 | 2,778.23 | 0.0416 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class A | RYAKX | 71 | 2,778.23 | 0.0416 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYMKX | 71 | 2,778.23 | 0.0416 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYRHX | 119 | 4,656.47 | 0.0376 |